sponsored content
August 15, 2024
When it comes to choosing a myopia management treatment modality, there are several factors to consider beyond just efficacy. Recently, Mark Bullimore, MCOptom, PhD, FAAO, Monica Jong, BOptom, PhD, and Noel Brennan, MScOptom, PhD, FAAO, published a paper entitled “Myopia Control: Seeing Beyond Efficacy” in Optometry and Vision Science. Now, Dr. Bullimore is sharing a summary of that paper, detailing exactly what factors practitioners should consider when choosing a treatment method beyond just the efficacy of different myopia control modalities. Watch the full video to learn about the importance of considering compliance, safety, quality of vision, and quality of life when treating myopia management patients:
Disclaimer: Johnson & Johnson owns and has exclusive rights to share the video, “Myopia control: seeing beyond efficacy.”
2024PP11199
